www Novo Nordisk CA - Search News

Novo Nordisk, Eli Lilly, Paramount, Nvidia, and more

Novo Nordisk Shares Plunge After Obesity Drug Fails to Beat Zepbound

Novo Nordisk NOVO.B -10.98% fell sharply after the Danish drugmaker said its CagriSema experimental obesity drug failed to beat the weight loss delivered by Eli Lilly’s LLY -1.34% Zepbound in a head-t...

· 13h · on MSN

Novo Nordisk's CagriSema trial deals blow in obesity drug battle with Eli Lilly

· 13h · on MSN

Novo Nordisk pitted a new weight-loss drug against Eli Lilly’s — and lost

· 4h

Novo Nordisk’s stock closes at 4-year low after its next-gen weight-loss drug lost to Lilly’s in Phase 3 trial

Novo Nordisk says a study found its experimental next-generation drug didn’t reduce as much weight as Eli Lilly’s Zepbound.

· 16h

Novo Nordisk's obesity drug CagriSema falls short against Eli Lilly's in trial

· 14h

Novo Nordisk Shares Plunge After Obesity Drug Fails to Beat Rival in Trial -- Update

Seeking Alpha

NOVO:CA Novo Nordisk A/S

Entering text into the input field will update the search result below Entering text into the input field will update the search result below

17don MSN

Novo Nordisk says generic Ozempic, Wegovy will slow sales in Canada

Novo Nordisk says the expiration of its patents for some semaglutide GLP-1 drug treatments in markets like Canada will result in more generics and hurt sales.

CNBC

Novo Nordisk CEO: Confident from supply perspective on the Wegovy pill Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your inbox, and more info about our ...